National Vision Holdings, Inc. (EYE): what the price assumes

In the published model solve dated 2026-Q2, anchored at $16.50, National Vision Holdings, Inc. (EYE) is priced for today's economics sustained for ~5.4 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-26.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/EYE

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 9.9% cost of capital; growth searched up to the 25% self-funding ceiling.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.2%); the inversion above states its own rate.

Per-Model Detail (n=15)

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

• National Vision runs the value end of American optical retail, with 1,057 America's Best stores at the close of fiscal 2025, and the eye exam is the traffic engine that sells the eyewear.
• The existing base is performing: "Comparable store sales growth and Adjusted Comparable Store Sales Growth from continuing operations for fiscal year 2025 were 5.9% and 6.0%, respectively", and the first quarter of fiscal 2026 carried that forward.
• The fragile piece is the store plan, which the company has scheduled to run at 30 to 35 openings a year before reaccelerating to roughly 60 a year beginning 2028; second-quarter results on August 7, 2026 are the next read on whether the base supports it.

Bull Case

The market prices this as a thin-margin retailer that has finally stopped shrinking. The store-level numbers describe something more interesting than that. The fiscal 2025 annual report records "Comparable store sales growth and Adjusted Comparable Store Sales Growth from continuing operations for fiscal year 2025 were 5.9% and 6.0%, respectively", and the first quarter of fiscal 2026 kept the pace: "Total net revenue of $543.9 million for the three months ended April 4, 2026 increased $33.6 million, or 6.6%, from $510.3 million for the three months ended March 29, 2025". Value retail growing existing stores at that rate is not a business in decline; it is a business whose economics the market has not yet decided to pay for.

The mechanism behind it is unusual enough to state plainly. America's Best sells an eye exam and two pairs of glasses for one low advertised price. The exam is close to a loss leader and the eyewear carries the margin, which means the doctor's chair, not the shelf, is the constraint on how much a store can sell. That inverts the ordinary retail problem. Most chains are limited by traffic; this one is limited by how many patients its optometrists can see in a day.

Which is why the capital plan reads the way it does. The company has told holders it will open "30 to 35 new stores per year in near term, primarily comprised of America's Best stores, while we invest in our strategic initiatives and expect to reaccelerate to approximately 60 per year beginning 2028, totaling approximately 240 new stores through 2030". The near-term slowdown is deliberate. Money is going into the existing base and into what the filing calls "continuing our implementation of remote medicine technologies", which lets one optometrist cover exam capacity across more than one location. If that works, every store in the fleet gets more productive without a single new lease being signed.

The portfolio is also cleaner than it was. During fiscal 2024 the Walmart store operations, together with parts of the AC Lens business, moved to discontinued operations. What is left is the owned-brand chain, and the comparable-store figures above describe that chain rather than a mix diluted by a host relationship the company no longer runs.

The capital returned to holders reinforces the read. The share count has been falling at about 3.7% a year since spring 2022, which is buyback deployment showing up in the one place it cannot be dressed up. The funded borrowing is a single term loan the annual report describes as "$237.6 million of term loan borrowings subject to variable interest rates with a weighted average borrowing rate of 5.6%", due in June 2028. The bear will point out that a thousand store leases are an obligation too, and the bear is right about that. The bull's answer is that the leases are matched against a sales line growing in the mid single digits, which is the condition under which fixed occupancy costs work in a retailer's favour rather than against it.

Bear Case

What the price is underwriting is not this year. It is a reacceleration the company has scheduled for 2028: roughly 30 to 35 store openings a year now, about 60 a year from that point, and something near 240 new stores through 2030. The most fragile assumption in that plan is not the count. It is that the marginal store earns like the average store, and the company's own risk disclosure describes why it might not: "opening new stores in our established markets may result in inadvertent oversaturation, temporarily or permanently divert customers and sales from our existing stores to new stores and reduce comparable store sales, thus adversely affecting our overall financial performance". A chain that adds stores into its own catchment areas can grow revenue and shrink store productivity at the same time, and the comparable-store number is where that shows up last.

Profitability leaves very little room for the plan to disappoint. Trailing operating income runs near 77.9 million dollars against roughly 2.02 billion dollars of revenue, a low-single-digit share of sales. That is normal for the value end of optical retail, but normal is not the same as resilient: a few points of gross margin, or a wage cycle, moves the whole operating line. Among the comparable set, COO converts 11.8% of revenue into operating profit and BLCO converts 4.4%, while WRBY currently runs an operating loss, which tells you the sector spans everything from comfortable to underwater and this company sits toward the thin end.

Then there is the obligation stack, and here the basis matters. On funded borrowings alone the net position is about 174.8 million dollars, which is unremarkable. Include the store lease obligations and the total obligation runs near 693.0 million dollars. For a retailer with more than a thousand locations, the lease is the debt: each store is a fixed multi-year commitment set against a sales line that varies with consumer spending and with how many optometrists the company can hire. Occupancy leverage is a wonderful thing while comps are positive and an unforgiving one when they are not.

Book value offers less of a floor than it appears to. The annual report puts "$606.5 million related to America's Best and $94.1 million related to Eyeglass World" of goodwill inside the Owned and Host segment, against a book value of $11.02 a share. Most of what sits on the balance sheet is therefore the price once paid for these chains rather than assets that could be sold to anyone else. That is precisely why the asset-based methods land so far under the current quote, and why an impairment cycle in a bad year would hit reported equity rather than protect it.

The labor constraint is the piece that could delay everything else. The filing is candid that demand for "optometrists in the current constrained labor market" has intensified and that the company competes for them against health systems and group practices as well as other retailers. Remote medicine is the answer management has chosen, and it may well be the right one. It is also an answer still being implemented, and until it demonstrably works, both the store plan and the productivity of the existing base are rationed by a labor market the company does not control.

None of this says the business is bad. The comparable-store record is genuinely good and the bull is entitled to it. The bear case is narrower and harder to dismiss: a thin operating margin, a large lease commitment, and a growth story whose acceleration is scheduled for a year that has not arrived yet.

Valuation

Two of the four families of method used here reach the price and two land well under it, which is an unusual split and the most informative thing in the whole exercise. Peer multiples and the cash-flow methods both defend today's quote. The asset-based methods and the earnings-power methods do not; the price sits far above where each of those families lands. That combination describes a business whose value is in the forward economics of its stores rather than in what it owns today or in what it currently earns.

The reason the asset lens comes up short is worth spelling out, because it is not a modelling quirk. Book value is $11.02 a share, and a large majority of that book is goodwill carried from the acquisitions that assembled the chains. The methods that build value from book equity plus excess returns then have very little to work with, since the return on equity the company is currently generating runs below the cost of equity a holder would demand. Under those two conditions those methods will always land near or below book, whatever the stores are worth as a going concern.

The going concern is what the price is actually buying. Read backwards, today's quote implies the current operating economics compounding at the fastest rate the business can fund from its own returns and holding that pace for roughly 5.4 years. Of comparable fast growers, only about 28% sustained such a pace that long. That is a demanding assumption rather than an outlandish one, which is consistent with two families reaching the price and two not. In business terms it means comps somewhere in the mid single digits, the existing base getting more productive, and the store cadence stepping up when the plan says it will.

The concrete demand sits in the operating margin. Trailing operating income of about 77.9 million dollars on roughly 2.02 billion dollars of revenue is a thin slice, and the plan requires that slice to widen while the company simultaneously funds new stores, remodels and the technology behind the exam capacity. Revenue growth alone will not do it; "Total net revenue of $543.9 million for the three months ended April 4, 2026 increased $33.6 million, or 6.6%, from $510.3 million for the three months ended March 29, 2025", and a similar increment repeated for years still leaves the margin question open unless the incremental revenue arrives at a better rate than the average.

On the balance sheet, the funded position is straightforward. The annual report describes "$237.6 million of term loan borrowings subject to variable interest rates with a weighted average borrowing rate of 5.6%", maturing in June 2028, with no further capacity available under that facility. Set beside the lease commitments the total obligation is several times larger, which is the honest way to read a retailer of this footprint. The share count has meanwhile fallen about 3.7% a year since spring 2022, so holders have been getting a slowly rising claim on whatever the stores end up earning.

Catalysts

Second-quarter fiscal 2026 results are scheduled for August 7, 2026. The number that matters in that release is the comparable-store figure rather than the headline revenue line, because the store-opening cadence is deliberately slow right now and the whole case rests on the existing base getting more productive while it is.

The first quarter, reported May 13, 2026, set the bar. Revenue reached $543.9 million for the three months ended April 4, 2026, up 6.6% on the prior-year quarter, and earnings came in above the consensus estimate for the period while revenue landed a shade under it. Management framed the quarter as evidence that the transformation plan laid out at its investor day is translating into results, which is the claim the August print will either extend or interrupt.

Two smaller developments since then bear on the same thesis. On June 24, 2026 the company announced a partnership with Rise Nano Optics to expand its lab network for specialty eyewear production, which touches the centralized laboratory capacity that finishes orders the stores cannot complete on site. On June 5, 2026 a director bought 50,000 shares in the open market. Neither moves a quarter. Both point the same direction as the capital plan the filings describe.

Peer Cohorts (Per Segment, With Filing Citations)

Owned & Host (reported)

• WRBY (Warby Parker Inc.)
• FY2025 10-K: …if they own significantly less than a majority of the outstanding shares of our Class A common stock, Class B common stock and Class C common stock, including the election of directors and significant corporate transactions, such as a merger or other sale of our company or its assets. Moreover, because we are…
• FY2025 10-K: …any reason by providing AWS notice and closing our account and which AWS may do for any reason by providing us at least 30 days' notice or (ii) terminated for cause, which either party may do if the other party has an uncured material breach and which AWS may do immediately upon notice. AWS does not have an…
• BLCO (Bausch & Lomb Corp)
• FY2025 10-K: …Our administrative, marketing, research/laboratory, distribution and warehousing facilities are located in various parts of the world. We co-locate our R&D activities with our manufacturing at the plant level in a number of facilities. Our scientists, engineers, quality assurance/quality control professionals and…
• FY2025 10-K: …BHC in connection with the B+L IPO (the "MSA"), until BHC ceases to hold 50% of the total voting power of our outstanding share capital entitled to vote in the election of our directors, we will not be permitted, without BHC's prior written consent, (or, in certain circumstances, the approval of the BHC Board of…
• COO (The Cooper Companies, Inc.)
• FY2025 10-K: …appearing in this report are the property of their respective holders. DEPENDENCE ON CUSTOMERS No customer accounted for 10% or more of our consolidated net revenue in fiscal 2025 and 2024. See Note 12. Business Segment Information of the Consolidated Financial Statements for additional information. SEASONALITY…
• FY2025 10-K: …progress. Through our Connection & Belonging (C&B) strategy, we drive a culture where individual qualities and backgrounds are highly valued and respected, and our employees feel a sense of belonging. Our C&B strategy includes initiatives to promote C&B conversations and training to inform and educate our workforce,…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.